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Abstract. To study the protective properties of pharmacological preconditioning with 
recombinant erythropoietin suberitro stimulating dose of 50 IU / kg in the retina of the eye, was 
the model of retinal ischemia, ischemia with the assessment of the temporary simulation mode of 
the retina of rats with the instrumental methods of analysis and morphometric studies. The most 
suitable model was a model 30 minute ischemia with subsequent reperfusion periods of 1 hour to 
72 hours. We studied the protective effect preconditioning suberitro stimulating recombinant 
erythropoietin in a dose of 50 IU/kg, preconditioning distant ischemic and emoxipine 2 mg/kg per 
rat model of retinal ischemia. In the experiment, it was revealed that the recombinant 
erythropoietin (50 IU/kg) prevents the development of degenerative retinal layers due to ischemic 
damage more than distant ischemic preconditioning and emoxipine. The observed protective 
effect of erythropoietin us with the development of ischemia was confirmed by laser Doppler 
flowmetry, electroretinography and morphometry. Using suberitro stimulating recombinant 
erythropoietin in a dose of 50 IU/kg, 30 minutes prior to the pathology simulation eliminates 
erythropoietic effect, and the lack of positive dynamics in groups with preliminary administration 
of glibenclamide 5 mg/kg, the key role of ATP-dependent potassium channels in a 
preconditioning mechanism implementation. Identification and use of pharmacological agents, 
which have the effect of preconditioning, may be a new approach in the correction and prevention 
of retinal ischemia, which is the leading element in the pathogenesis of a number of visual 
pathologies. The possibility of pharmacological preconditioning with erythropoietin ischemic 
lesions of the retina is essential for the development of anti-ischemic agents for the treatment and 
prevention of ocular pathologies of ischemic origin. 
Keywords: ischemia-reperfusion of the retina; pharmacological preconditioning; erythropoietin; 
emoxipine; ATP-dependent potassium channels. 
 
Introduction. 
In recent years, been an increase in ischemic 
diseases of the eye associated with the spread of 
atherosclerosis, arterial hypertension, coronary artery 
disease, diabetes mellitus, which lead to diseases of 
the vascular system of the eye. Ischemia is one of the 
leading causes of low vision, blindness and 
disability-free for people of different age groups [1]. 
In this regard, prevention and correction of the 
consequences of ischemia, developing in various 
pathological conditions, it is an actual problem of 
modern medicine. That is why the study of ways to 
improve tissue tolerance to ischemia is an actual 
problem of modern experimental and clinical 
pharmacology. 
Treatment available to date, medications may 
not always be successful enough, that ensures the 
relevance of the problem to expand the arsenal of 
drugs for the treatment of ocular diseases associated 
with ischemic conditions [2]. 
Due to the fact that the leading element in the 
pathogenesis of a number of vascular diseases of the 
fundus is the retinal ischemia [3], prevention and 
correction of ischemic diseases of the retina is an 
actual problem of modern ophthalmology and 
pharmacology, which can be solved with the help of 
pharmacological preconditioning, the essence of 
which consists in the activation of endogenous 
protective mechanisms that reduce the extent of 
damage in the subsequent prolonged ischemic 
episode [4]. 
It is proved that the use of recombinant 
erythropoietin (EPO) in small doses has no effect on 
peripheral blood, whereas the positive effects on 
brain tissue [5] and myocardium [6], skin flap [7], 
kidney [8], endotelioprotection persists [9]. 
In connection with the above, it should be noted 
study the relevance of protective effects of EPO on a 
model of retinal ischemia-reperfusion. 
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Objective: to increase the effectiveness of 
pharmacological correction of retinal ischemia with 
use of distant ischemic preconditioning and 
pharmacological preconditioning with recombinant 
erythropoietin. 
Materials and methods. 
Experiments were carried out on the Wistar 
rats weighing 225- 275 g. For the study the rats 
were taken with no external signs of disease, 
passed quarantine regime. 
Operations and other manipulations were 
performed on rats under general anesthesia 
performing intraperitoneal (i/p) adding an 
aqueous solution of chloral hydrate 300 mg/kg. 
DIP was performed 10 min by the clamping 
the femoral artery to the proximal tourniquet third 
hip for 40 min before modeling retinal ischemia 
followed by a 30 minute episode-reperfusion 
injury [10]. 
Recombinant erythropoietin was administered 
i/p (Epokrin, GosNII OCHB (State Research 
Institute of especially pure biological products) in 
a dose of 50 IU/kg 30 minutes before the 
pathology simulation. 
Glibenclamide ("Maninil" (Berlin-Chemie 
AG/ Menarini Group) was administered at a dose 
of 5 mg/kg once per 60 min before ischemia 
simulations. 
Emoxipine, solution for injection, 10 mg/ml 
(vials) 1 ml (1% Solution), (Federal State Unitary 
Enterprise "Moscow Endocrine Plant") was 
administered at a dose of 2 peribulber mg/kg. 
Introduction of the preparation was carried out once 
daily for 4 days including the first administration 30 
min before modeling pathology. 
Measuring the level of microcirculation in the 
retina of rats was performed by LDF. Registration is 
carried out by means of hardware and software 
Biopac-systems MP-150 and the needle-type sensor 
TSD-144 (USA) with AcqKnowledge 4.2 
program. After anesthesia the animal, carried out an 
assessment of the microcirculation level in ten points 
on the circumference of the eyeball, the recording 
duration of the microcirculation level readings at one 
point was twenty seconds. From the microcirculation 
level results at every point of the average volumes, 
which was taken as the indicator of the level of the 
microcirculation in the retina of the experimental 
animal. Indicator microcirculation in the group of 
animals was calculated as the average of the values 
obtained from each experimental animal group [11]. 
For registration of the ERG animals were 
kept in the dark for 30 minutes [12], then 
anesthetized (chloral hydrate, 300 mg/kg, i/p) and 
fixed on the table is isolated from the 
electromagnetic radiation. Corneal silver 
electrode was placed on the cornea, pre-wetted 
with saline to more fully contact the 
reference EL needle electrode 452 placed 
subcutaneously in the skull, EL450 ground needle 
electrode was placed subcutaneously in the base 
of the tail. Strobe light with white flash connected 
to the stimulator STM200 company Biopac System, 
Inc. (USA) placed behind the back of the animal, 
ERG registration was carried out in response to a 
single stimulation. Evoked bio potentials were run 
at a frequency of 1-1000 Hz, amplified, averaged 
and presented graphically on the screen using the 
Biopac-systems MP-150 with a computer program 
AcqKnowledge 4.2 (USA). ERG recording was 
carried out for 0.5 seconds of each rat in groups to 
assess the degree of retinal ischemia evaluated by the 
ratio of the amplitudes of the a- and b- wave ERG - 
coefficient b/a (Neroev VV et al., 2004) [13]. Report 
the average, which was added to the protocol from 
the obtained ten values in each group. 
After the LDF and ERG eyes with surrounding 
tissues subject to enucleation. The obtained sample 
was fixed in 10% formalin solution for the iµmersion 
method phosphate buffer for 24 hours. 
Then, subject to the eyeball enucleation. For 
histological examination with eyes iµmediately, 
adjacent tissues were fixed in 10% formalin 
solution. After fixation, the material is completely 
embedded in paraffin wax in the standard 
mode. Slices oriented in the blocks so as to receive 
the slices in the manufacture of preparations in the 
meridian direction substantially through the middle 
of the eyeball. Sections for standard histological 
examination and stained with hematoxylin-eosin. A 
descriptive study of histological preparations were 
performed under a microscope Axio Scope A1 (Carl 
Zeiss Microimaging GMbH, Germany) [14]. The 
morphometric studies were performed on the 
microscope Mikmed-6, JSC "LOMO" with the use of 
the program Micro-Analysis View. 
For all these descriptive statistics were used: 
data are checked for normal distribution. Type 
defines the criteria for the distribution of the Shapiro-
Wilk. In case of normal distribution were calculated 
the average value (M) and standard error of the mean 
(m). In cases of abnormal distribution were 
calculated median (Me) and quartile range (QR). 
Between-group differences were analyzed by 
parametric (t-Student criterion) or non-parametric 
(Mann-Whitney test) methods, depending on the type 
of distribution. Differences were determined at 0.05 
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significance level. Statistical analyzes were 
performed using Statistica 10.0 software. 
The main part: 
The first step in the study of pharmacological 
preconditioning protective properties of the retina is 
the development of models of retinal ischemia. 
Based on literature data, modeling laboratory 
rats retinal ischemia can be carried out by raising 
the intraocular pressure (IOP). This model was 
performed by Pathology of the needle connected to 
a saline solution container, in the anterior chamber 
of the eye. Further, the capacity is raised to the 
desired height, creating the necessary IOP [15]. 
The present method model of retinal ischemia-
reperfusion injury, has drawbacks and limitations 
associated with damage to the anterior chamber, the 
additional administration of antibacterial drugs to 
prevent infection with the eye [16]. 
In connection with the above, our own 
modification of the model of retinal ischemia-
reperfusion was used, in which increased intraocular 
pressure is carried out by mechanical pressure (110 
mm Hg) In the anterior chamber of the eye. 
5 series of experiments carried out to search for 
the optimum time of retinal ischemia. The first 
group (n = 20) - the group of intact animals, second 
(n = 20) - a group of animals to the duration of 
retinal ischemia 10 min, and the third (n = 20) - to 
ischemia lasting for 20 minutes, and the fourth (n = 
20) - with a length 30 minutes ischemia, fifth (n = 
20) - with a 40 min ischemia. After 
anesthesia i/p introducing an aqueous solution of 
chloral hydrate 300 mg/kg, the animal was fixed in a 
lateral position, and then carried ischemia. After the 
simulation after 1 h and 72 h of reperfusion 
microcirculation was measured in the retina by 
LDF, determined electrophysiological condition of 
the retina by the ERG and the excretion of animals 
was carried out, followed by enucleation of eyes for 
morphological studies. 
After working models and choosing the optimal 
time simulation retinal ischemia surveyed 
retinoprotective activity distant ischemic 
preconditioning and pharmacological 
preconditioning with recombinant erythropoietin 
compared to the reference drug emoxipine. 
Results.  
In accordance with the study design, modeling 
the duration of retinal ischemia was 10, 20, 30 and 
40 min, followed by reperfusion period duration 1 h 
and 72 h. 
In accordance with the protocol simulation 
pathology after 1 hour and 72 hours of reperfusion 
the animals were performed anesthesia (chloral 
hydrate solution 300 mg/kg rat body weight).Then 
evaluated the level of the microcirculation by LDF, 
we evaluated electrophysiological condition of the 
retina by ERG, and then taken out of animal 
experiments followed by enucleation eye for 
morphological and morphometric study of the 
retina. 
After modeling retinal ischemia (IR) rats by 
providing mechanical pressure on the anterior 
chamber after 1 h post-ischemic reperfusion formed 
reactive hyperemia. 
The results of measuring the level of 
microcirculation rat retina after 1 h reperfusion 
depending on the duration of ischemia are shown in 
fig. 1. The level of retinal microcirculation intact 
animals was 743.6 ± 20.9 p.u.. After 1 hour after the 
pathology simulation group of animals from 30 min 
ischemia, the level of microcirculation was 1135.2 ± 
43.4 p.u. that exceeds the level of microcirculation 
under the group of intact animals by 52%, in the 
group of animals with 40 min ischemia indicator of 
microcirculation was 1164.9 ± 34.5 p.u., exceeding 
the figure in the group of intact animals by 57%. In 
groups of 10, and 20 min ischemia of the 
microcirculation level exceeded the figure relative 
to the group of intact animals by 23% and 33%, 
respectively. The data obtained in all the 
experimental groups was significantly different from 
that of the group of intact animals. 
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Figure 1. Level retinal microcirculation 1 hour after retinal ischemia simulations 
Note. * - p <0.05 compared with the group of intact animals. 
 
After modeling IR rats by providing 
mechanical pressure on the anterior chamber after 
72 hours post-ischemic reperfusion observed 
deterioration in regional blood flow, which is 
associated with the development of the pathological 
cascade of morphological and functional changes in 
the eye. 
The data obtained during the measurements in 
the microcirculation retina of rats after 72 h of 
reperfusion, depending on the duration of ischemia 
are shown in Fig. 2. The level of the 
microcirculation in the retina intact animals was 
740.0 ± 8.1 p.u.. After 72 hours, the animals in 
groups with a duration of ischemia, 30 and 40 min 
levels microcirculation reached the least results. In 
the group of animals with 30 min ischemia of the 
microcirculation level was 346.1 ± 11.5 p.u., which 
is 53% lower than this indicator in the group of 
intact animals. In the group of 40 min ischemia 
microcirculatory level was 294.4 ± 17.9 p.u., below 
the level of microcirculation in the intact group by 
60%. In the case of 10 and 20 minutes of retinal 
ischemia model of microcirculation level was lower 
than in the group of animals intact 15% and 34%, 
respectively. During simulation pathology in all 
experimental groups, a significant difference is 
observed between the level of microcirculation 
indices in the group of intact animals. 
Based on these results, it should be noted that 
the duration of ischemic episodes caused by 
increased intraocular pressure greatly affects the 
level of retinal microcirculation after 1 h and 72 h 
after reperfusion pathology simulation. 
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Figure 2. The level of the microcirculation in the retina after 72 h after modeling retinal ischemia. 
Note. * - p <0.05 compared with the group of intact animals. 
 
Violations result in hemodynamic changes 
characteristic of ischemia in the study of retinal 
electrophysiological state. To assess the severity of 
retinal ischemia is used with respect to the amplitude 
of the wave b wave amplitude a ERG, which allows 
to evaluate the severity of retinal ischemia - 
coefficient b/a [13]. 
Fig. 3 shows the results of changing the ratio of 
the amplitudes of a- and b- waves electroretinogram - 
ratio b/a 1 h after reperfusion, retinal ischemia 
simulations of 10, 20, 30 and 40 min. 
In the experimental evaluations of 
electrophysiological condition of the retina of rats, it 
was found that the ratio b/a in the group of intact 
animals was 2.5 ± 0.08 r.u., in groups IR lasting 30 
and 40 minutes, modeling the figure was significantly 
different from the values in the group of intact 
animals and amounted to 2.1 ± 0.08 and 2.0 ± 0.06 
r.u. which is lower than under the group of intact 
animals by 16% and 20%, respectively. In the groups 
of IR 10 and duration 20 min significant differences 
from the values in the group of intact rats were 
revealed. 
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Figure 3. Evaluation of retinal electrophysiological state 1 hour after modeling retinal ischemia. 
Note. * - p <0.05 compared with the group of intact animals. 
 
Fig. 4 shows the change in the coefficient b/a 
within 72 h after reperfusion, retinal ischemia 
simulations of 10, 20, 30 and 40 min. 
After 72 h of reperfusion in all experimental 
groups showed a significant contrast ratio b/a of the 
electroretinogram values in the group of intact 
animals. This indicator reached the level of 2.1 ± 
0.07 r.u. in the group with the 10-min 
ischemia, which is lower than with respect to the 
group of intact animals by 16%. In the group with the 
20-min ischemia ratio b/a was 1.8 ± 0.08 r.u., which 
is below this indicator relative to the group of intact 
animals by 28%. In the group with the 30-min 
ischemia ratio b/a was equal to 1.2± 0.06 r. u., which 
is below this indicator relative to the group of intact 
animals by 52%. In the group with the 40-min 
ischemia ratio b/a was 1.1 ± 0.03 r.u.  in the group, 
which is lower than this indicator relative to the 
group of intact animals by 56%. 
Based on the conclusion that the modeling of 
pathology can be made of data is a violation of the 
electrophysiological state of the inner layers of the 
retina, which is characterized by a decrease in the 
electrophysiological activity of the bipolar, Muller 
cells, amacrine and horizontal cells, due to 
violations of the retinal blood flow and the 
occurrence of ischemia. 
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Figure 4. Assessment of retinal electrophysiological state 72 hours after modeling retinal ischemia. 
Note. * - p <0.05 compared with the group of intact animals. 
 
Changing the ratio b/a of the electroretinogram 
in the experimental groups occurred after 72-hours  
eperfusion, more pronounced, than in the 
experimental groups at 1 hour of reperfusion, which 
is associated with the development of degenerative 
changes in the retina that occurred during this time. 
After electroretinography analyzed 
morphometric parameters of retina. Morphometric 
assessment was subject to the inner nuclear layer and 
photoreceptor layer of the retina of experimental 
animals. 
Example of measuring the inner nuclear layer 
thickness and the photoreceptor layer is given in Fig. 
5 and Fig. 6, respectively. 
In the morphometric analysis of the inner 
nuclear layer thickness and a layer of photoreceptors 
was determined after 1 h reperfusion in duration with 
IP groups 10 and 20 minutes, increasing the thickness 
of the inner nuclear layer was not significantly 
different from the group of intact animals. In the 
experimental groups with 30 min and 40 min 
ischemia thickness of the inner nuclear layer was 
significantly different from the group of intact 
animals. As a result of the morphometric analysis 
photoreceptor layer thickness it was found that 
significant differences in all the experimental groups 
with respect to no group intact. 
An example of a morphometric analysis through 
1 hour after pathology simulation presented in Fig. 7 
and 8. Results of morphometric 1 h after reperfusion 
are shown in Tab. 1. 
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Figure 5. An example of measuring the thickness of the inner nuclear layer of the retina intact animal.  
H & E stain. Increasing the X400 
 
 
 
Figure 6. Example of measurement of the thickness of the retinal photoreceptor layer is intact animal eyes.  
H & E stain. Increasing the X400 
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Figure 7. An example of morphometric measurements of the inner nuclear layer of the retina thickness rats 1 hour after 
reperfusion disease modeling (30 minute model). Ochre. hematoxylin and eosin. Increase 0 x40. 
 
 
 
Figure 8. Example morphometric measurement of the thickness of the retinal photoreceptor layer of the rat at 1 hour 
after reperfusion disease modeling (30 minute model). H & E stain. Increasing the X400. 
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Table 1. 
The thickness of the inner nuclear layer and retinal photoreceptors in rat experimental groups after 1 h reperfusion  
(M ± m; n = 10) 
No Experimental groups Inner nuclear layerthickness, µm 
The thickness of the 
photoreceptor, µm 
1. Intact 23.6 ± 0.69 38.2 ± 0.95 
2. IR 10 min 24.0 ± 0.74 38.5 ± 0.73 
3. IR 20 min 24.4 ± 0.86 38.6 ± 0.63 
4. IR 30 min 25.8 ± 0.65 * 38.8 ± 0.64 
5. IR 40 min 26.1 ± 0.70 * 39.1 ± 0.74 
Note. * - P <0.05 compared with the group of intact animals 
 
Thickness of the inner nuclear layer of the retina 
intact rats was 23.6 ± 0.69 µm. In the group of 
animals with a model of ischemia and 40 minutes, 30 
of the inner nuclear layer thickness was 25.8 ± 0.65 
µm and 26.1 ± 0.70 µm, respectively, which was 
significantly different from the index of the group of 
intact animals. 
Morphometrically picture retinal layers after 72 
h of reperfusion is shown in Fig. 9. and Fig. 10. 
 
 
 
Figure 9. Example morphometric measurement of the thickness of the inner nuclear layer of the retina of rat after 72 
hours of reperfusion with a moment disease modeling (30 minute model). H & E stain. Increasing the X400. 
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Figure 10. Example morphometric measurements of the retinal photoreceptor layer thickness rats 72 hours after 
reperfusion disease modeling (30 minute model). H & E stain. Increasing the X400. 
 
These morphometric study of the retina eyes 
of animals 72 hours after pathology  
simulation are presented in Table. 2. 
Table 2. 
The thickness of the inner nuclear layer and retinal photoreceptors in rat experimental groups, after 72 h  
of reperfusion (M ± m; n = 10) 
No Experimental groups Inner nuclear layerthickness, µm 
The thickness of the 
photoreceptor, µm 
1. Intact 23.4 ± 0.61 38.0 ± 0.89 
2. IR 10 min 22.2 ± 0.84 38.1 ± 0.67 
3. IR 20 min 21.7 ±0.61 37.3 ± 0.66 
4. IR 30 min 20.4 ± 0.80 * 36.6 ± 0.65 
5. IR 40 min 19.5 ± 0.51 * 36.1 ± 0.69 
Note. * - P <0.05 compared with the group of intact animals 
 
After 72 hours of reperfusion, animals in groups 
ah model of ischemia 10 and 20 m thickness of the 
inner nuclear layer was not significantly different 
from this index in the group of intact animals. The 
groups ah animal models of ischemia 30 and 40 min 
thickness of the inner nuclear layer was 20.4 ± 
0.83 µm and 19.5 ± 0.51 µm respectively that differs 
significantly from the index of the group of intact 
animals, after 72 h of reperfusion. Results 
morphometry photoreceptor layer in all experimental 
groups showed no statistically significant differences. 
Study: microcirculation level in the retina by 
LDF, electrophysiological activity by ERG, 
morphometric parameters, allowed us to estimate the 
degree of damage to the retina at the pathology of 
this model depending the duration of ischemic 
episodes. 
Most acceptable (from our perspective) model is 
a model of a 30-minute IC, which is characterized by: 
 statistically significant difference in the level 
of retinal microcirculation in rats after 1 hour and 72 
hours after reperfusion by IP indicators group of 
intact animals; 
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 significant reduction index b/a simulation 
pathology of electroretinogram after 1 hour and 72 
hours of reperfusion compared with those in the 
group of intact animals; 
  statistically significant difference between 
morphometric parameters of the layers of the retina 
relative to the group of intact animals. 
After working pathology model evaluated 
protective effect of ischemic preconditioning distant 
and recombinant erythropoietin compared to 
emoxipine. 
Estimated at the level of the microcirculation in the 
retina, after pathology simulation was carried out after 1 
h and 72 h of reperfusion by LDF. The results obtained 
after 1 hour of reperfusion are shown in Tab. 3. 
The level of the microcirculation in the retina 
intact rats was 738,9 ± 37.6 p.u.  The level of 
microcirculation after ischemia simulations in the 
control group reached after 1 h of reperfusion 1155.0 
± 51.9 p.u. , which was significantly higher than the 
value in the group intact farm animals 
(p <0.05). Against the background of the correction 
of pathology DIP level of microcirculation in the 
retina after 1 h of reperfusion significantly reduced to 
952.0 ± 25.8 p.u.  (p <0.05) compared with 
the control group (IC) (Tab. 3). 
Table 3. 
The level of the microcirculation in the retina of rats After 1 h of reperfusion (M ± m), PE 
Number 
pp 
experimental groups 
The level of the 
microcirculation 
1. Intact (n = 10) 738.9 ± 37.6 у 
2. Control (n = 10) 1155.0 ± 51.9 * 
3. Correction DIP (n = 10) 952.0 ± 25.8 * y 
4. Correction EPO, 50 IU/kg (n = 10) 798.5 ± 12.3 у 
5. Control + glibenclamide 5 mg/kg (n = 10) 1135.8 ± 31.2 * 
6. Correction DIP + glibenclamide 5 mg/kg (n = 10) 1144.7 ± 20.7 * 
7. Correction EPO, 50 IU/kg + glibenclamide 5 mg/kg (n= 10) 1148.5 ± 14.3 * 
8. Correction emoxipin, 2 mg/kg (n = 10) 998.0 ± 19.4 * y 
Note. * - P <0.05 compared with the group of intact animals; 
y
 - p <0.05 compared with the control group 
 
When the correction of the modeled pathology 
EPO microcirculation level in the group is reduced to 
798.5 ± 12.3 p.u.  and also significantly different from 
the values in the control group (p <0,05). Pretreatment 
of Emoxipine led to a decrease in the level of 
microcirculation to 998.0 ± 19.4 p.u. Introduction 
glibenclamide, a blocker of ATP-sensitive potassium 
channels in the group correction DIP EPO and 
prevented reduction of microcirculation, which 
confirms the action precondition recombinant EPO at a 
dose of 50 IU / kg to retinal ischemia model of rats after 
1 hour of reperfusion. 
The results of evaluation of microcirculation level 
in rat retina after 72 hours after reperfusion and its IR 
simulation DIP correction EPO at a dose of 50 IU/kg 
and emoxipin 2 mg / kg are presented in Table. 4. 
The level of the microcirculation in the retina 
intact rats was 743.9 ± 5.0 p.u.  The level of 
microcirculation after IC simulation in the control group 
was 72 h after reperfusion 353.3 ± 11.7 p.u. which was 
significantly lower than in the group of intact animals (p 
<0.05), indicating that the formation of ischemia 
reperfusion for 72 hours . Against the background of the 
correction of pathology DIP level of microcirculation in 
the retina after 72 h of reperfusion significantly 
increased to 638.5 ± 15.8 p.u.  (p <0.05) compared with 
the control group (Tab. 4). 
Table 4 
The level of the microcirculation in the retina after 72 h of reperfusion (M ± m), p.u. 
Number 
pp 
experimental groups 
The level of the 
microcirculation 
1. Intact (n = 10) 743.9 ± 5.0 y 
2. Control (n = 10) 353.3 ± 11.7 * 
3. Correction DIP (n = 10) 638.5± 15.8 * y 
4. Correction EPO, 50 IU/kg (n = 10) 724.0 ± 4.1 y 
5. Control + glibenclamide 5 mg/kg (n = 10) 359.4 ± 10.3 * 
6. Correction DIP + glibenclamide 5 mg/kg (n = 10) 361.7 ± 13.9 * 
7. Correction EPO, 50 IU/kg + glibenclamide  
5 mg/kg (n = 10) 
372.3 ± 13.4 * 
8. Correction emoxipin, 2 mg/kg (n = 10) 672.3 ± 12.7 * y 
Note. * - P <0.05 compared with the group of intact animals; 
y
 - p <0.05 compared with the control group 
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When the correction of the modeled pathology 
EPO microcirculation level in the group increased to 
724.0 ± 4.1 p.u. , which was significantly different 
from the values in the control group (p <0.05), and 
tends to the value in the group of intact animals. In 
the group of animals treated with emoxipine 
microcirculation level was 672.3 ± 12.7 p.u.  
Group Introduction glibenclamide correction 
DIP and EPO prevented improving microcirculation, 
which confirms the presence precondition 
recombinant EPO effect in a dose of 50 IU/kg per rat 
model of retinal ischemia reperfusion after 72 hours. 
After simulating ischemia and measuring the 
level of the microcirculation in the retina was 
performed on electroretinography evoked 
potential. The data obtained are presented in Table. 5. 
Table 5 
The results of evaluation of retinal electrophysiological state after 1 h of reperfusion (M ± m; n = 10) 
Number 
pp 
Experimental groups b/a, r.u. 
1. Intact 2.6 ± 0.09 y 
2. Control 2.0 ± 0.09 * 
3. Correction DIP 2.3 ± 0.07 * y 
4. Correction EPO, 50 IU/kg 2.5 ± 0.07 y 
5. Control + glibenclamide 5 mg/kg 2.2 ± 0.06 * 
6. Correction DIP + glibenclamide 5 mg/kg 2.1 ± 0.08 * 
7. Correction EPO, 50 IU/kg + glibenclamide 5 mg/kg 2.2 ± 0.09 * 
8. Correction emoxipin, 2 mg/kg (n = 10) 2.3 ± 0.09 y 
Note. * - P <0.05 compared with the group of intact animals; 
y
 - p <0.05 compared with the control group 
  
Ratio b/a in the control group was 2.0 ± 0.09 
conventional units, which was significantly different 
from the group of intact animals. Increase of this 
indicator in the group with the correction of 
recombinant EPO to 2.5 ± 0.07 r.u. and DIP - up 
to 2.3 ± 0.07 r.u. says the preservation of retinal 
function after electrophysiological disease 
modeling. In the group of animals with the correction 
emoxipin ratio b/a was 2.3 ± 0.09 r. u., which was 
significantly different from that of the group with 
retinal ischemia and approaches the values in the 
group of intact animals. 
Introduction of glibenclamide in the groups of 
animals with the correction of the EPO and DIP led 
to a decrease in the index b/a to values significantly 
different from that of the group of intact animals, 
indicating that the blockade of the ATP-dependent 
potassium channel and confirms the presence of 
precondition properties of EPO in a dose of 50 IU/kg 
and DIP IR model for 1 h after reperfusion. 
Conducting the ERG at 72 h after reperfusion 
was performed measuring the level of retinal 
microcirculation in experimental animals. The results 
of the study are presented in Table. 6. 
Table 6 
The results of evaluation of retinal electrophysiological state after 72 h of reperfusion (M ± m; n = 10) 
No Experimental groups b / a, r. u 
1. Intact 2.5 ± 0.10 y 
2. Control 1.2 ± 0.04 * 
3. Correction DIP 2.0 ± 0.08 *y 
4. Correction EPO, 50 IU/kg 2.3 ± 0.06 y 
5. Control + glibenclamide 5 mg/kg 1.2 ± 0.05 * 
6. Correction DIP + glibenclamide 5 mg/kg 1.2 ± 0.0 4 * 
7. Correction EPO, 50 IU/kg + glibenclamide 5 mg/kg 1.2 ± 0.06 * 
8. Correction emoxipin, 2 mg/kg (n = 10) 2.1 ± 0.07  *y 
Note. * - P <0.05 compared with the group of intact animals; 
y
 - p <0.05 compared with the control group 
 
The coefficient b / a in the control group was 1.2 
± 0.04 relative units, statistically significantly 
different from that of the group of intact animals. The 
increase of this indicator in the group with the 
correction of recombinant EPO to 2.3 ± 0.06 r. u., 
DIP - to 2.0 ± 0.08 r. u. and emoxipine to 2.1 ± 0.07 
r. u. talks about maintaining electrophysiological 
retinal function after IR simulation. 
Introduction of glibenclamide in groups of rats 
with the correction of the EPO and DIP led to a 
reduction coefficient b/a to values significantly 
different from the group of intact rats, indicating that 
the blockade of the ATP-dependent potassium 
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channel and confirms the presence of precondition 
properties of EPO in a dose of 50 IU/kg and DIP on 
IR model after 72 h of reperfusion. 
Reducing the ratio b/a in animals with simulated 
ischemia (control) due to inhibition of the positive b-
wave ERG, which indicates violation of 
electrophysiological function of bipolar and Muller 
cells with the possible contribution of the horizontal 
and amacrine cells. Saving the electrophysiological 
function of the photoreceptor layer is confirmed by 
the absence of adverse changes in the wake 
of a. Example b-wave suppression electroretinogram 
is shown in Fig. 3.9. 
Electroretinogram retinas of rats experimental 
groups №1-8 (Tab. 6) are shown in Fig. 11, 12, 13, 
14. 
 
 
 
 
 
Figure 11. Electroretinogram retina of rats: A - ERG retina intact animal; B - ERG animal retinal ischemia  
(inhibition observed b-wave of electroretinogram) after 72 h of reperfusion 
b - wave 
a - wave 
А 
b - wave 
a - wave 
B 
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Figure 12. Retina ERG in rats after 72 h of reperfusion in the experimental groups:  
A - correction of the EPO; B - correction DIP. 
 
 
B 
А 
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Figure 13. ERG retina of rats after 72 h of reperfusion in the experimental groups:  
A - control + glibenclamide; B - correction DIP + glibenclamide. 
B 
А 
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Figure 14. ERG retina of rats after 72 h of reperfusion in the experimental groups:  
A - EPO correction + glibenclamide; B - correction emoxipin. 
 
 
B 
А 
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After the ERG, eye enucleation was subject to 
subsequent morphometric analysis. Morphometric 
assessment subject to the inner nuclear layer and 
photoreceptor. Morphometry of retinal layers was 
carried out by Micro-Analysis View 
software. Results of morphometric analysis after DIP 
correction EPO emoxipine and combined use with 
glibenclamide, reperfusion after 1 hour are shown in 
Table. 7. 
An example of measuring the thickness of the 
inner nuclear layer and a layer of photoreceptors in 
the group of animals with EPO is shown in Figure 15 
and Figure 16, respectively. 
 
  
 
Figure 15. Example morphometric measurement of thickness of the inner nuclear layer of the retina rats 1 hour after 
reperfusion of EPO on a background correction. H & E stain. Increased X400. 
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Figure 16. Example of morphometric measurements of the retinal photoreceptor layer thickness rat through 1:00 reperfusion 
on the background correction of EPO. H & E stain. Increasing the X400. 
 
During the morphometric analysis of the 
inner nuclear layer and a photoreceptor layer 
thickness it was found that after 1 hour of reperfusion 
in the control group increased thickness of the inner 
nuclear and of 25.9 ± 0.6 µm, which is significantly 
different group of intact animals. 
Pretreatment of EPO reduces the thickness of 
the inner nuclear layer to 23,8±0.6 µm, which was 
significantly different from the control group, and is 
close to the values in the group of intact animals. In 
the group with DIP and emoxipine thickness of the 
inner nuclear layer was 24.0 ±0.5 µm 
and 24.2±0.4 µm, respectively, figures significantly 
differ from the control group. Pretreatment with 
glibenclamide in a group with EPO DIP and led to an 
increase the thickness of the inner nuclear layer, the 
indicators in groups made up 25.8 ±0.6 µm 
and 25.7±0.6 µm, respectively, which was 
significantly different from the group of intact 
animals and confirms the protective effect of 
preconditioning on the retina, where the key role 
played by K
+
-ATP channels. Measurements of the 
photoreceptor layer showed no statistically 
significant differences in the groups. 
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 Table 7 
Morphometric indices retinal layers experimental animals 1 hour after reperfusion (M ± m; n = 10) 
No Experimental groups The inner nuclear layer, µm A layer of photoreceptors, µm 
1. Intact 23.5± 0.8 y 38.4 ± 0,8 
2. Control 25.9 ± 0.6 * 39.1 ± 0,7 
3. DIP 24.0 ± 0.5 y 38.4 ± 0,9 
4. EPO 23.8± 0.6 y 38.3 ± 0,9 
5. Control + Glibenclamide 26.0 ± 0.7 * 39.1 ± 0,6 
6. DIP + Glibenclamide 25.8 ± 0.6 * 39.2 ± 0,6 
7. EPO + Glibenclamide 25.7 ± 0.6 * 39.0 ± 0,5 
8. Emoxipine 24.2 ± 0.4 y 38.6 ± 0,6 
Note. * - P <0.05 compared with the group of intact animals; 
y
 - p <0.05 compared with the control group 
 
Morphometry results confirmed the data 
obtained by ERG changes b - wave of ERG, 
accompanied by changes in the inner nuclear layer, 
preserving a - wave of ERG, accompanied by a lack 
of photoreceptor layer changes. 
The results of morphometric analysis after a 
DIP correction EPO emoxipine and combined use 
with glibenclamide, after 72 hours of reperfusion are 
shown in Table. 8. 
Table 8 
Morphometric indices retinal layers experimental animals at 72 hours of reperfusion (M ± m; n = 10) 
No Experimental groups The inner nuclear layer, µm A layer of photoreceptors, µm 
1. Intact 23.8 ± 1.0 y 38.1 ± 1.2 
2. Control 20.3 ± 0.8 * 36.9 ± 0.9 
3. DIP 21.7 ± 0.4 * y 37.8 ± 0.8 
4. EPO 23.3 ± 0.7 y 38.0 ± 1.0 
5. Control + Glibenclamide 20.5 ± 0.4 * 37.1 ± 0.8 
6. DIP + Glibenclamide 20.6 ± 0.6 * 36.9 ± 0.8 
7. EPO + Glibenclamide 20.3 ± 0.5 * 37.0 ± 0.9 
8. Emoxipine 22.5 ± 0.5 y 37.8 ± 0.9 
Note. * - p <0.05 compared with the group of intact animals; 
y
 - p <0.05 compared with the control group 
  
In the morphometric analysis revealed that 
significant changes in photoreceptor layer thickness 
after 72 hours of reperfusion in animals of 
experimental groups is not observed in any of the 
series, that confirms the absence of a negative change 
- ERG wave. 
Most sensitive to the action of 
ischemia/reperfusion turned inner nuclear layer. After 
72 hours, the thinning observed in connection with 
ischemic processes in the retina, in the group of 
animals with the simulation pathology inner nuclear 
layer thickness was 20.3 ± 0.8 µm, which is 
significantly different from the group of intact 
animals. 
In the group of animals treated with EPO, inner 
nuclear layer thickness after 72 hours of reperfusion 
was 23.3 ± 0.7 µm, which is significantly different 
from the group with the IR values. 
In the group with DIP and in the group with 
emoxipine inner nuclear layer thickness was 21.7 ± 
0.4 µm and 22.5 ± 0.5 µm respectively. 
Pretreatment with glibenclamide contributed to 
the elimination of protective actions as DIP and EPO, 
confirming the presence of anti-ischemic effect on 
the model of retinal ischemia in rats DIP and EPO in 
a dose of 50 IU/kg by precondition action. 
In all experimental groups, the thickness of the 
layer of photoreceptors had no statistically significant 
differences. 
Morphometry results in 72 hours of reperfusion 
confirmed the data obtained by the ERG, 
oppression b - wave of ERG, due to the thinning of 
the inner nuclear layer, and the preservation of 
negative a - wave of ERG, accompanied by a lack of 
photoreceptor layer changes. 
The study found that EPO has a stronger 
retinoprotective action compared with DIP and 
emoxipine that after pathology simulation confirmed 
changes in microcirculation line retina through 1 
hour, 72 hours of reperfusion resulted in 
normalization of ERG and morphometric parameters 
of the experimental groups. 
Use of EPO suberitrostimulating dose of 50 IU / 
kg 30 minutes prior to simulation, the action 
precludes eritrostimulating EPO and increased 
resistance to ischemic retinal tissue. 
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Pretreatment with glibenclamide abolished the 
beneficial effects of EPO and DIP, which indicates 
the implementation retinoprotection by 
preconditioning, the mechanism of which is realized 
at the expense of ATP-sensitive potassium channels. 
Emoxipine at a dose of 2 mg/kg has a less 
pronounced effect than retinoprotection DIP 1 hour 
of reperfusion, but was superior to the performance 
indicators DIP 72 hours. 
Discussion 
The main factors of development of IR are: 
breach of the general hemodynamics, local changes 
in the walls of blood vessels and coagulation and 
lipoprotein changes in the blood. The first factor is 
usually caused by GB, hypotension, atherosclerosis, 
diabetes, occlusive diseases of the large blood 
vessels, blood diseases. From local changes are the 
most important vessels atheromatosis, violations of 
the vascular endothelium [16, 17, 18, 19]. 
In this connection there is a need to find new 
methods for retinoprotection possible reduction in the 
damaging effect of ischemia and reperfusion of the 
retina. Segment of drugs to treat diseases of the 
choroid as the complications of systemic diseases is 
expedient to expand due to the increasing incidence 
of and lack of funds for targeted ischemic lesions of 
the choroid correction [20]. 
As drugs for correcting retinal ischemic damage 
is nonspecific therapy and do not have the desired 
result, that the problem can be solved by AF, which 
is able to protect the retina from ischemic injury. 
The role of the DIP and the PT proved by many 
authors in various organs and tissues of the 
body. Versatility preconditioning mechanism gives 
the background to the study of this phenomenon on 
the retina. One of the most promising is the 
AF EPO agents precondition his action has been 
studied in the brain [21], the spinal 
cord [22], kidney [23], the small 
intestine [24] heart[25, 26]. 
ATP-dependent potassium channel opening 
during ischemia, plays a central role in the 
mechanism of cytoprotective effect of SP. Initially, 
their activity was detected at sarcolemma membrane, 
and later at the mitochondrial level. Those and other 
isoforms are inhibited by physiological 
concentrations of intracellular ATP and open when 
the concentration of ATP is significantly reduced, 
that is, act as sensors (sensors) the availability of 
sufficient amounts of oxygen and glucose (ATP 
source) [27]. 
Because most researchers tend to believe that all 
their isoforms are able to participate in the 
implementation of the protective effect of 
preconditioning in the study, we used a non-selective 
blocker of ATP-sensitive potassium channels, 
glibenclamide. 
Given the fact that these electrophysiological 
studies often have a decisive importance in the early 
and differential diagnosis of retinal disorders [28], to 
study the correction of degenerative changes in the 
retina, you must conduct a comprehensive analysis, 
including electroretinography, microcirculatory and 
morphological studies. Analysis of the dynamics of 
retinal electrogenesis allows you to evaluate the 
nature and topography of retinal disorders, as well as 
to identify the most labile hypoxic retinal structure, 
their response to recombinant EPO DIP correction 
and emoxipin. 
The foregoing predetermined the need to 
develop and systematize methodological approaches 
to the assessment of the functional state of the retina 
and the subsequent optimization of the correction of 
ischemic damage of the retina. 
So, in the course of our research in the 
experiment on Wistar rats had developed a set of 
methodological approaches to assess the functional 
status of the retina, which includes tools (LDF, ERG) 
and morphological methods. 
The first step in exploring the possibility of 
correction of ischemic damage to the retina using 
distant and pharmacological preconditioning with 
recombinant EPO was to develop a model of retinal 
ischemia Wistar laboratory rats. A prerequisite was to 
study the effect of different time periods of ischemia 
on functional condition of the retina. To do this, we 
evaluated the microcirculation level in the retina, 
electrophysiological and morphological picture of the 
state of the layers of the retina followed by 
morphometry of the most important layers. 
Simulation IR laboratory rats was performed by 
raising IOP to 110 mm Hg while providing 
mechanical pressure to the anterior chamber. After 
simulating ischemia lasting 10, 20, 30 and 40 minutes 
of retinal condition evaluation was carried out after 1 
h and 72 h of reperfusion. This time period is selected 
based on the literature [29]. After the simulation IR 
through 1 hour post-ischemic reperfusion reactive 
hyperemia is formed. After the simulation IR rats at 
72 hours post-ischemic reperfusion observed 
deterioration in regional blood flow. 
After examining the functional status of the 
retina instrumental methods of analysis and 
morphometric studies was the most appropriate 
model is a 30-minute IR. Such a period of 1 hour 
after ischemia reperfusion, contributed to an increase 
of the inner nuclear layer and resulted in pronounced 
degenerative changes at 72 hours of reperfusion, 
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which were not observed at 10 and 20 minutes of 
ischemia. 
Summarizing the above, it should be noted that 
the proposed method complex functional and 
morphological changes associated with the 
development of IR, be sufficient to objectively assess 
retinoprotective effects of pharmacological agents. 
The results of investigating the possibility of IR 
correction using distant and pharmacological 
preconditioning recombinant EPO have determined 
that in the groups of the experimental animals treated 
with EPO, there was a significant difference between 
all the measured parameters (level of 
microcirculation in the retina, the values of the 
coefficient b/a of electroretinogram, the thickness of 
the retinal layers) on the values of in the group of 
animals with IR, which makes it possible to talk 
about the ability of EPO at a dose of 50 IU / kg 
retinoprotection exert effects on IR model 
experiment. 
Coefficient value b/a ERG and the thickness 
of the inner nuclear layer of the retina in the group 
correction DIP statistically significantly different 
from the values in the control group and the group of 
intact animals, which makes it impossible to speak 
about full retinoprotection, which is observed in the 
group of animals treated with the EPO. 
Proof of protection layers of the retina due to the 
effect of preconditioning served in the additional 
administration of glibenclamide 5 mg / kg dose, 
blocking ATP-dependent potassium channels. In 
groups of animals treated with correction DIP and 
EPO administration of glibenclamide resulted in the 
elimination of the observed cytoprotective effect, 
which confirms precondition effect of DIP and 
recombinant EPO in a dose of 50 IU / kg on an 
experimental IR model, the mechanism of realization 
of which is the basis of the activation of ATP-
dependent potassium channels . 
The results obtained in the group of animals 
with emoxipin correction comparable to the group 
correction DIP, but inferior performance in the group 
correction EPO. 
Thus, the prospects become apparent to optimize 
pharmacotherapy conditions accompanied by retinal 
ischemia, which are closely linked with the task of 
forming the methodology of the study antiischemic 
activity of pharmacologic agents based on an 
adequate assessment of the functional condition of 
the retina instrumental and morphological studies. 
Optimization pharmacological IP correction may 
be performed by specific recombinant EPO therapy at 
a dose of 50 IU / kg and DIP, since in both cases 
there is a positive pharmacological effect. 
Conclusion: 
The study developed a model of retinal 
ischemia, with justification temporary ischemia 
simulation mode of the retina of rats, assessment of 
the level of microcirculation, retinal 
electrophysiological state and morphometric 
parameters of retina, allow to fully appreciate the 
functional condition of the retina after a period of 
ischemia followed by reperfusion. The optimum 
pathology model was a model 30-minute ischemia 
with subsequent retinal reperfusion periods lasting 1 
hour to 72 hours. 
This model allowed us to estimate the 
possibility of retinal preconditioning with 
recombinant erythropoietin at a dose of 50 IU/kg 
and distant ischemic preconditioning. A single 
injection of recombinant erythropoietin in a dose of 
50 IU/kg 30 minutes before the pathology 
simulation resulted in reduced microcirculatory 
level 1 hour after reperfusion, retinal preservation 
electrophysiological activity, which is also 
confirmed by morphometric. Distant ischemic 
preconditioning conducted 40 minutes before the 
disease modeling, after 1 hour of reperfusion helped 
prevent damage to the retinal tissue is less 
pronounced compared to the group with pre-
administration of recombinant erythropoietin. Pre 
peribulber emoxipine administration at a dose of 2 
mg / kg resulted in a less pronounced effect 
retinoprotecion compared with recombinant 
erythropoietin and distant ischemic preconditioning. 
After 72 hours of reperfusion, the most 
pronounced retinoprotective action was observed in 
the group of animals with pharmacological 
preconditioning recombinant erythropoietin in a 
dose of 50 IU / kg distant ischemic preconditioning 
rendered less effective protective effect on the 
retinal tissue in comparison with the group of 
animals with daily peribulber emoxipine 2 mg / kg. 
Pretreatment with glibenclamide 5 mg / kg, 
offsetting the positive effects provided by 
erythropoietin at a dose of 50 IU / kg and distant 
ischemic preconditioning, which confirms the 
implementation retinoprotection by preconditioning, 
carried out with the participation of ATP-dependent 
potassium channels. 
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